Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)

SHE:300519 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	560.28	503.42	543.95	622.03	593.67	591.85
Trading Asset Securities	170	185	155	115	125	85
Cash & Short-Term Investments	730.28	688.42	698.95	737.03	718.67	676.85
Cash Growth	-0.76%	-1.51%	-5.17%	2.56%	6.18%	8.24%
Accounts Receivable	8.58	12.58	10.74	25.48	17.51	20.72
Other Receivables	0.01	0.04	0.18	0.04	0.16	0.04
Receivables	8.59	12.62	10.92	25.52	17.67	20.76
Inventory	49.4	69.34	71.42	46.15	46.76	42.92
Other Current Assets	3.88	4.34	3.89	3.57	2.82	2.36
Total Current Assets	792.16	774.71	785.17	812.26	785.92	742.9
Property, Plant & Equipment	102.44	105.52	115.47	114.88	114.68	112.84
Long-Term Investments	21.34	21.42	21.4	20.37	20.54	22.68
Other Intangible Assets	7.8	7.88	8.17	9.28	10.41	11.54
Long-Term Deferred Tax Assets	0.19	0.25	0.2	0.93	0.82	0.77
Other Long-Term Assets	-	-	-	0.03	0.04	0.05
Total Assets	923.93	909.78	930.41	957.76	932.4	890.79
Accounts Payable	50.29	56.01	63.88	56.75	56.11	36.33
Accrued Expenses	0.68	3.17	11.14	17.82	12.89	9.75
Current Income Taxes Payable	5.96	7.18	0.76	12.82	5.34	5.34
Current Unearned Revenue	2.55	0.07	0.16	0.14	0.09	0.21
Other Current Liabilities	1.15	4.18	1.15	0.84	0.79	0.69
Total Current Liabilities	60.63	70.61	77.08	88.37	75.22	52.31
Long-Term Unearned Revenue	5.94	6.28	6.84	7.71	8.15	8.78
Long-Term Deferred Tax Liabilities	-	-	-	0.43	0.45	0.39
Other Long-Term Liabilities	2.36	2.36	2.36	2.36	2.36	2.36
Total Liabilities	68.93	79.25	86.29	98.86	86.19	63.84
Common Stock	160	160	160	160	160	160
Additional Paid-In Capital	161.29	161.29	161.29	161.29	161.29	161.29
Retained Earnings	530.48	505.94	519.55	535.19	522.37	503.45
Comprehensive Income & Other	3.24	3.31	3.29	2.42	2.56	2.2
Shareholders' Equity	855.01	830.53	844.12	858.89	846.22	826.94
Total Liabilities & Equity	923.93	909.78	930.41	957.76	932.4	890.79
Net Cash (Debt)	730.28	688.42	698.95	737.03	718.67	676.85
Net Cash Growth	-0.76%	-1.51%	-5.17%	2.56%	6.18%	8.24%
Net Cash Per Share	4.49	4.24	4.34	4.61	4.46	4.24
Filing Date Shares Outstanding	163.61	177.91	160	160	160	160
Total Common Shares Outstanding	163.61	177.91	160	160	160	160
Working Capital	731.53	704.11	708.09	723.9	710.69	690.58
Book Value Per Share	5.23	4.67	5.28	5.37	5.29	5.17
Tangible Book Value	847.2	822.66	835.95	849.61	835.8	815.4
Tangible Book Value Per Share	5.18	4.62	5.22	5.31	5.22	5.10
Buildings	-	-	116.47	112.48	95.23	95.03
Machinery	-	-	120.9	124.97	120.21	115.56
Construction In Progress	-	-	11	1.95	11.35	3.34

Source: S&P Global Market Intelligence. Standard template. Financial Sources.